Skip to main content
OpenTrials
Completed

NCT Number: NCT03187613

Correlation of Metamorphopsia and Aniseikonia to Retinal Shift Following Retinal Detachment Surgery

Individuals operated for rhegmatogenous retinal detachment will be prospectively evaluated for postoperative retinal shift. Fundus autofluorescence will be used to evaluate retinal shift that will be correlated to visual acuity, metamorphopsia, aniseikonia, and stereopsis.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Stavanger University Hospital, Department of Ophthalmology

Stavanger, 4016, Norway

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Acute rhegmatogenous retinal detachment, fovea detached, able to signe

Exclusion criteria

  • Secondary retinal detachment like tractional, serous or with ora serrata dialysis, fovea on

Treatment and study plan

Primary outcomes

  1. Retinal shift

    Time frame: 2 years

    Measured on fundus autofluorescence

Secondary outcomes

  1. Visual acuity

    Time frame: 6 and 24 months

    Best Corrected Visual Acuity

  2. Metamorphopsia

    Time frame: 6 and 24 months

    M-Chart

  3. Aniseikonia

    Time frame: 6 and 24 months

    New Aniseikonia Test

  4. Stereopsis

    Time frame: 6 and 24 months

    Titmus Test

Sponsors and collaborators

Lead sponsor

Helse Stavanger HF

Other Gov

Registry information

Important dates

Study start
2017
Primary completion
2020
Study completion
2020
First posted
Jun 15, 2017
Registry last updated
Sep 28, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.